Embecta Long Term Debt 2021-2025 | EMBC
Embecta long term debt from 2021 to 2025. Long term debt can be defined as the sum of all long term debt fields.
|
Embecta Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $1,596 |
| 2023 | $1,625 |
| 2022 | $1,631 |
| 2021 | |
| 2020 | |
|
Embecta Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1,488 |
| 2025-03-31 | $1,539 |
| 2024-12-31 | $1,565 |
| 2024-09-30 | $1,596 |
| 2024-06-30 | $1,621 |
| 2024-03-31 | $1,623 |
| 2023-12-31 | $1,624 |
| 2023-09-30 | $1,625 |
| 2023-06-30 | $1,627 |
| 2023-03-31 | $1,628 |
| 2022-12-31 | $1,629 |
| 2022-09-30 | $1,631 |
| 2022-06-30 | $1,632 |
| 2022-03-31 | $1,601 |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.851B | $1.123B |
| Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $156.252B | 28.69 |
| HCA Healthcare (HCA) | United States | $107.856B | 17.86 |
| CVS Health (CVS) | United States | $98.775B | 11.36 |
| Elevance Health (ELV) | United States | $72.412B | 10.62 |
| Cencora (COR) | United States | $70.172B | 22.64 |
| Natera (NTRA) | United States | $28.194B | 0.00 |
| DiDi Global (DIDIY) | China | $24.803B | 20.27 |
| Labcorp Holdings (LH) | United States | $22.125B | 16.87 |
| Medpace Holdings (MEDP) | United States | $16.622B | 41.27 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.514B | 0.00 |
| Solventum (SOLV) | United States | $13.123B | 12.74 |
| ICON (ICLR) | Ireland | $13.097B | 13.00 |
| Viatris (VTRS) | United States | $12.347B | 4.60 |
| CochLear (CHEOY) | Australia | $11.709B | 0.00 |
| Revvity (RVTY) | United States | $10.513B | 19.36 |
| HealthEquity (HQY) | United States | $8.768B | 35.09 |
| Charles River Laboratories (CRL) | United States | $8.259B | 15.91 |
| Avantor (AVTR) | United States | $7.759B | 11.85 |
| Sonic Healthcare (SKHHY) | Australia | $6.885B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.729B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.771B | 34.41 |
| Bausch + Lomb (BLCO) | Canada | $5.525B | 36.28 |
| Sotera Health (SHC) | United States | $4.443B | 21.42 |
| GeneDx Holdings (WGS) | United States | $3.702B | 65.01 |
| Amplifon S.p.A (AMFPF) | Italy | $3.560B | 20.77 |
| Alignment Healthcare (ALHC) | United States | $3.306B | 0.00 |
| Concentras Parent (CON) | United States | $2.489B | 15.54 |
| Premier (PINC) | United States | $2.327B | 22.55 |
| Progyny (PGNY) | United States | $2.117B | 41.61 |
| Pediatrix Medical (MD) | United States | $1.988B | 11.87 |
| Surgery Partners (SGRY) | United States | $1.976B | 25.47 |
| Organon (OGN) | United States | $1.958B | 2.06 |
| Establishment Labs Holdings (ESTA) | $1.859B | 0.00 | |
| PACS (PACS) | United States | $1.612B | 0.00 |
| Ardent Health (ARDT) | United States | $1.289B | 4.21 |
| Teladoc Health (TDOC) | United States | $1.228B | 0.00 |
| Omada Health (OMDA) | $1.161B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.008B | 16.50 |
| CareDx (CDNA) | United States | $0.820B | 13.39 |
| InnovAge Holding (INNV) | United States | $0.657B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.610B | 8.41 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| Nutex Health (NUTX) | United States | $0.595B | 9.01 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.499B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.434B | 0.00 |
| Enhabit (EHAB) | United States | $0.409B | 18.39 |
| Strata Critical Medical (SRTA) | United States | $0.391B | 0.00 |
| Pomdoctor - (POM) | China | $0.386B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.383B | 5.76 |
| Oncology Institute (TOI) | United States | $0.371B | 0.00 |
| So-Young (SY) | China | $0.369B | 0.00 |
| SBC Medicals (SBC) | United States | $0.344B | 6.25 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| KindlyMD (NAKA) | United States | $0.270B | 0.00 |
| Agilon Health (AGL) | United States | $0.239B | 0.00 |
| LifeMD (LFMD) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.163B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 33.37 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| Biodesix (BDSX) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 7.21 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |